価格表

在庫・価格 : 2025年04月30日 17時59分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
GDF-11, Human, Recombinant <BMP-11>
データシート
1958-GD-010 RSDアールアンドディー システムズ
R&D Systems, Inc.
10 μg ¥86,000
(未発注)
追加

在庫・価格 : 2025年04月30日 17時59分 現在

GDF-11, Human, Recombinant <BMP-11>

  • 商品コード:1958-GD-010
  • メーカー:RSD
  • 包装:10μg
  • 価格: ¥86,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Hocking JC et al. TGFbeta ligands promote the initiation of retinal ganglion cell dendrites in vitro and in vivo. Mol. Cell. Neurosci. 2008 Feb;37(2):247-60
Hocking JC et al
2008/01/01
Species: Xenopus, Application: Bioassay, Whole Cells PubMed
2 Castonguay R et al. Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growth. J. Biol. Chem. 2011 Aug;286(34):30034-46
Castonguay R et al
2011/01/01
Application: Surface Plasmon Resonance, Sample Type: recombinant Endoglin PubMed
3 Li Y et al. NKX2-1 activation by SMAD2 signaling after definitive endoderm differentiation in human embryonic stem cell. Stem Cells Dev. 2013 May;22(9):1433-42
Li Y et al
2013/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
4 Carrancio S et al. An activin receptor IIA ligand trap promotes erythropoiesis resulting in a rapid induction of red blood cells and haemoglobin. Br. J. Haematol. 2014 Jun;165(6):870-82
Carrancio S et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
5 Dussiot M et al. An activin receptor IIA ligand trap corrects ineffective erythropoiesis in &#x3B2;-thalassemia. Nat. Med. 2014 Apr;20(4):398-407
Dussiot M et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
6 Latres E et al. Myostatin blockade with a fully human monoclonal antibody induces muscle hypertrophy and reverses muscle atrophy in young and aged mice. Skelet Muscle 2015;5:34
Latres E et al
2015/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
7 Walker RG et al. Structural basis for potency differences between GDF8 and GDF11. BMC Biol. 2017 Mar;15(1):19
Walker RG et al
2017/01/01
Application: Bioassay,In Vivo, Sample Type: In Vivo,Whole Cells PubMed
8 Hammers DW et al. Supraphysiological levels of GDF11 induce striated muscle atrophy. EMBO Mol Med 2017 Apr;9(4):531-544
Hammers DW et al
2017/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
9 Lee SB et al. Maltose binding protein-fusion enhances the bioactivity of truncated forms of pig myostatin propeptide produced in E. coli. PLoS ONE 2017;12(4):e0174956
Lee SB et al
2017/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
  • No.: 1
  • 文献情報:
    Hocking JC et al. TGFbeta ligands promote the initiation of retinal ganglion cell dendrites in vitro and in vivo. Mol. Cell. Neurosci. 2008 Feb;37(2):247-60
    Hocking JC et al
    2008/01/01
  • 備考:
    Species: Xenopus, Application: Bioassay, Whole Cells
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Castonguay R et al. Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growth. J. Biol. Chem. 2011 Aug;286(34):30034-46
    Castonguay R et al
    2011/01/01
  • 備考:
    Application: Surface Plasmon Resonance, Sample Type: recombinant Endoglin
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Li Y et al. NKX2-1 activation by SMAD2 signaling after definitive endoderm differentiation in human embryonic stem cell. Stem Cells Dev. 2013 May;22(9):1433-42
    Li Y et al
    2013/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Carrancio S et al. An activin receptor IIA ligand trap promotes erythropoiesis resulting in a rapid induction of red blood cells and haemoglobin. Br. J. Haematol. 2014 Jun;165(6):870-82
    Carrancio S et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Dussiot M et al. An activin receptor IIA ligand trap corrects ineffective erythropoiesis in &#x3B2;-thalassemia. Nat. Med. 2014 Apr;20(4):398-407
    Dussiot M et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Latres E et al. Myostatin blockade with a fully human monoclonal antibody induces muscle hypertrophy and reverses muscle atrophy in young and aged mice. Skelet Muscle 2015;5:34
    Latres E et al
    2015/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Walker RG et al. Structural basis for potency differences between GDF8 and GDF11. BMC Biol. 2017 Mar;15(1):19
    Walker RG et al
    2017/01/01
  • 備考:
    Application: Bioassay,In Vivo, Sample Type: In Vivo,Whole Cells
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Hammers DW et al. Supraphysiological levels of GDF11 induce striated muscle atrophy. EMBO Mol Med 2017 Apr;9(4):531-544
    Hammers DW et al
    2017/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Lee SB et al. Maltose binding protein-fusion enhances the bioactivity of truncated forms of pig myostatin propeptide produced in E. coli. PLoS ONE 2017;12(4):e0174956
    Lee SB et al
    2017/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed